documents: FDA-2022-N-3012-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-N-3012-0001 FDA FDA-2022-N-3012 Teva Branded Pharmaceutical Products R and D, Inc., et al.; Withdrawal of Approval of 35 New Drug Applications Notice Withdrawal 2022-12-08T05:00:00Z 2022 12 2022-12-08T05:00:00Z   2022-12-08T15:58:52Z 2022-26661 0 0 0900006485524e02

Links from other tables